Mannitol is Used for assessing bronchial hyperresponsiveness in patients over 6 years old without clinically apparent asthma. It was first introduced by B Braun Medical Inc in its drug Mannitol 5% on Approved Prior to Jan 1, 1982. Other drugs containing Mannitol are Osmitrol 5% In Water, Mannitol 15% W/ Dextrose 5% In Sodium Chloride 0.45%, Mannitol 25%, Osmitrol 20% In Water, Osmitrol 20% In Water In Plastic Container, Mannitol 20%, Osmitrol 10% In Water In Plastic Container, Bronchitol, Aridol Kit, Mannitol 5% W/ Dextrose 5% In Sodium Chloride 0.12%, Mannitol 20% In Plastic Container, Osmitrol 5% In Water In Plastic Container, Mannitol 10%, Mannitol 15% In Plastic Container, Mannitol 10% W/ Dextrose 5% In Distilled Water, Osmitrol 10% In Water, Osmitrol 15% In Water In Plastic Container, Mannitol 5% In Plastic Container, Osmitrol 15% In Water, Mannitol 10% In Plastic Container, Mannitol 15%, Resectisol, Resectisol In Plastic Container. 13 different companies have introduced drugs containing Mannitol.

Mannitol Patents

Given below is the list of patents protecting Mannitol, along with the drug name that holds that patent and the company name owning that drug.

Download patent list as spreadsheet

Get the complete list right in your inbox!

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Aridol Kit	US5817028	Method and device for the provocation of air passage narrowing and/or the induction of sputum	Feb 23, 2015 (Expired)	Pharmaxis Europe

Add above patents to watchlist

Mannitol's Family Patents

Full family tree

Mannitol Generic API Manufacturers

Several generic applications have been filed for Mannitol. The first generic version for Mannitol was by Fresenius Kabi Usa Llc and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Igi Laboratories Inc and was approved on May 6, 1987.

Given below is the list of companies who have filed for Mannitol generic, along with the locations of their manufacturing plants worldwide.